Michael Lee Milligan

Insider Reports History

Location
Watertown, MA
Signature
/s/ Michael Lee Milligan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Lee Milligan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Title: Chief Financial Officer & Principal Accounting Officer Common Stock 21,034 $74,986 $3.56 17 Feb 2026 Direct
Neumora Therapeutics, Inc. Title: Chief Financial Officer & Principal Accounting Officer Stock Option (Right to Buy) 350,000 08 Jan 2026 Direct

Insider Reports Filed by Michael Lee Milligan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMRA Neumora Therapeutics, Inc. 17 Feb 2026 1 -$5,119 4 Title: Chief Financial Officer & Principal Accounting Officer 19 Feb 2026, 17:04
NMRA Neumora Therapeutics, Inc. 08 Jan 2026 1 $0 4 Title: Chief Financial Officer & Principal Accounting Officer 09 Jan 2026, 16:20
NMRA Neumora Therapeutics, Inc. 28 May 2025 10 $0 4 Title: Chief Financial Officer & Principal Accounting Officer 30 May 2025, 18:31
NMRA Neumora Therapeutics, Inc. 18 Feb 2025 1 -$3,351 4 Title: Chief Financial Officer & Principal Accounting Officer 20 Feb 2025, 17:14
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 9 $0 4 Title: Chief Financial Officer & Principal Accounting Officer 18 Feb 2025, 16:30
NMRA Neumora Therapeutics, Inc. 14 Feb 2024 2 $0 4 Title: SVP Finance & Principal Accounting Officer 16 Feb 2024, 16:14
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Title: SVP Finance & Principal Accounting Officer; Exhibit 24 - Power of Attorney 18 Sep 2023, 15:11